Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: New insights on mechanisms of action Article

Osei, K, Rhinesmith, S, Gaillard, T et al. (2003). Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: New insights on mechanisms of action . 52(5), 565-572. 10.1053/meta.2003.50111

cited authors

  • Osei, K; Rhinesmith, S; Gaillard, T; Schuster, D

sustainable development goals

authors

publication date

  • May 1, 2003

keywords

  • BETA-CELL
  • DEFECTS
  • Endocrinology & Metabolism
  • Life Sciences & Biomedicine
  • MELLITUS
  • NIDDM
  • NON-HISPANIC WHITES
  • PATHOGENESIS
  • PREVALENCE
  • PREVENTION
  • RESISTANCE
  • RISK
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • W B SAUNDERS CO

start page

  • 565

end page

  • 572

volume

  • 52

issue

  • 5